- Home
- Free App Analytics
- Linus Participant
- Linus Participant Vs. Longevity Participant
Linus Participant vs Longevity Participant Usage & Stats
Linus Participant allows you to participate in research studies and clinical trials from the comfort of your own home. The user experience is designed for simplicity to minimize burden.
Features:
- Single click to start available assessment
- View of upcoming schedule of assessments
- Notification reminders
- Apple App Store
- Free
- Medical
Store Rank
- -
Longevity Participant by Applied Cognition, Inc is a clinical research smartphone application that uses keyboard sensor data to collect and measure biomarkers of cognition through patterns in the way you type. Longevity Participant only collects typing patterns and timings of keystrokes. Longevity Participant DOES NOT collect any content from your typing. Data collected by Longevity Participant is used solely for the purposes of clinical research, and is protected health information covered by HIPAA. Longevity Participant app requires prior consent and approval to participate in studies authorized to use the Longevity service by Applied Cognition, Inc. Please note that if you have NOT consented to participate in a clinical research study requiring longevity access and have not signed appropriate consent forms, please refrain from using this application and consult your study admin for more information.
The Longevity Participant app is intended for use on a mobile device only. Please refrain from using this app on an iPad.
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
Linus Participant vs. Longevity Participant ranking comparison
Compare Linus Participant ranking trend in the past 28 days vs. Longevity Participant
Rank
No Data Available
Linus Participant vs. Longevity Participant ranking by country comparison
Compare Linus Participant ranking trend in the past 28 days vs. Longevity Participant
No Data to Display
Compare to any site with our free trial
Linus Participant VS.
Longevity Participant
January 3, 2025